olprinone has been researched along with Acute Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, K; Kosugi, S; Kotake, Y; Morisaki, H; Satoh, T; Serita, R; Takeda, J; Yamamoto, M | 1 |
| Goto, Y | 1 |
| Hayashi, M; Himura, Y; Kawai, C; Kumada, T; Nakamura, Y; Tanio, H | 1 |
1 review(s) available for olprinone and Acute Disease
| Article | Year |
|---|---|
[How to use PDE III inhibitors].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 3; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Pyridones; Randomized Controlled Trials as Topic | 2007 |
2 other study(ies) available for olprinone and Acute Disease
| Article | Year |
|---|---|
Olprinone, a phosphodiesterase III inhibitor, reduces gut mucosal injury and portal endotoxin level during acute hypoxia in rabbits.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Carbon Dioxide; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Progression; Dose-Response Relationship, Drug; Endotoxins; Hydrogen-Ion Concentration; Hypoxia; Imidazoles; Intestinal Mucosa; Male; Organ Size; Oxygen Consumption; Phosphodiesterase Inhibitors; Portal Vein; Pyridones; Rabbits; Splanchnic Circulation | 2003 |
Hemodynamic efficacy of E-1020 in comparison with dopamine on acute mitral regurgitation in anesthetized dogs.
Topics: Acute Disease; Animals; Cardiotonic Agents; Dogs; Dopamine; Heart Failure; Hemodynamics; Imidazoles; Mitral Valve Insufficiency; Myocardial Contraction; Pyridones; Stimulation, Chemical | 1991 |